• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LIFECORE BIOMEDICAL, LLC DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE; AID, SURGICAL, VISCOELASTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LIFECORE BIOMEDICAL, LLC DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE; AID, SURGICAL, VISCOELASTIC Back to Search Results
Catalog Number ASKU
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Bacterial Infection (1735); Conjunctivitis (1784); Endophthalmitis (1835); Visual Impairment (2138); Fibrosis (3167); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 05/10/2023
Event Type  Injury  
Event Description
A nurse reported that after 14 days of cataract surgery, patient experienced endophthalmitis in right eye vision decrease, positive for p.Acne.It was treated with intravitreal tap procedure and antibiotics and steroid medications.Current patient condition was unknown.Before surgery patient's bcva was 20/50 -2 and after surgery 20/cf 1 ft.Patient had conjunctival inflammation was <2+, aqueous cell was 3+, aqueous fibrin was present, hypopyon was absent.Intravitreal tap and injection of vancomycin, ceftazadime and dexamethasone used as a intervention for the events.It was unknown whether the intervention for the events effective or not.No sutures used, no surgical complications.
 
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Manufacturer Narrative
Additional information is provided in sections h.6 and h.10.All batches are released according to the required specifications.A lot code would be required for review of the complaint history and the batch documentation.Adverse events are followed-up by medical safety.No product returned for evaluation.Inconclusive, no product returned: as no product returned and all initial testing results are within specification a conclusive root cause could not be determined.All batches are released according to the required specifications.None - no product returned/insufficient information: as no product is returned, the complaint could not be verified and therefore no capa is initiated.However further trending is performed.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DUOVISC OPHTHALMIC VISCOSURGICAL DEVICE
Type of Device
AID, SURGICAL, VISCOELASTIC
Manufacturer (Section D)
LIFECORE BIOMEDICAL, LLC
3515 lyman boulevard
chaska MN 55318
Manufacturer (Section G)
LIFECORE BIOMEDICAL, LLC
3515 lyman boulevard
chaska MN 55318
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key17133624
MDR Text Key317209116
Report Number2184002-2023-00002
Device Sequence Number1
Product Code LZP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P840064
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 10/06/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberASKU
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/17/2023
Initial Date FDA Received06/15/2023
Supplement Dates Manufacturer Received09/12/2023
Supplement Dates FDA Received10/06/2023
Was Device Evaluated by Manufacturer? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
CEFTADAZIME; DEXAMETHASONE; PREDNISOLONE; VANCOMYCIN
Patient Outcome(s) Other; Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-